Guinea vs Zambia: Population requiring preventive chemotherapy for schistosomiasis
Guinea
4.21 million
in 2024
Zambia
4.79 million
in 2024
Guinea rank
20th
Zambia rank
17th
Population requiring preventive chemotherapy for schistosomiasis over time
- Guinea
- Zambia
How they compare
Zambia currently reports 4.79 million against 4.21 million in Guinea, a difference of 583,970.
That makes Zambia's figure about 1.1 times Guinea's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Zambia ahead.
Guinea ranks 20th and Zambia ranks 17th of 52 countries.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.98 million | 4.65 million | 1.66 million | Zambia |
| 2020s | 4.42 million | 4.50 million | 80,660 | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Guinea or Zambia?
- Zambia, at 4.79 million against 4.21 million in Guinea as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Guinea and Zambia?
- 583,970, with Zambia ahead.
- How many years of comparable data are there for Guinea and Zambia?
- 15 years are reported by both, from 2010 to 2024.
- How do Guinea and Zambia rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Guinea ranks 20th and Zambia ranks 17th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.